Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells

Liu,Mi‑Hua; Lin,Xiao‑Long; Li,Jian; He,Jun; Tan,Tian‑Ping; Wu,Shao‑Jian; Yu,Shan; Chen,Li; Liu,Jun; Tian,Wei; Chen,Yu‑Dan; Fu,Hong‑Yun; Yuan,Cong; Zhang,Yuan

doi:10.3892/mmr.2015.4695

February-2016 Volume 13 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2016 Volume 13 Issue 2

Full Size Image

Article

Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells

Authors:
- Mi‑Hua Liu
- Xiao‑Long Lin
- Jian Li
- Jun He
- Tian‑Ping Tan
- Shao‑Jian Wu
- Shan Yu
- Li Chen
- Jun Liu
- Wei Tian
- Yu‑Dan Chen
- Hong‑Yun Fu
- Cong Yuan
- Yuan Zhang
View Affiliations / Copyright

Affiliations: Department of Clinical Laboratory, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Pathology, The Third People's Hospital of Huizhou Affiliated to Guangzhou Medical University, Huizhou, Guangdong 516002, P.R. China, Department of Ultrasonic Diagnosis, BoAi Hospital of Zhongshan, Zhongshan, Guangdong 528403, P.R. China, Department of Cardiology, The First Hospital of Changsha, Changsha, Hunan 410005, P.R. China, Department of Pathology, Mawangdui Hospital, Changsha, Hunan 410016, P.R. China
Pages: 1689-1694
|
Published online on: December 18, 2015

https://doi.org/10.3892/mmr.2015.4695
Expand metrics +

Abstract

Resveratrol is a polyphenolic compound found in wine, which is mainly produced by the grapevine and exerts chemopreventive effects against hepatocellular carcinoma. However, the underlying molecular mechanisms have remained to be fully elucidated. The present study assessed whether resveratrol-induced apoptosis was mediated via the activation of the forkhead box O3a (FoxO3a) transcription factor. It was demonstrated that resveratrol treatment induced apoptosis in HepG2 cells, and that this pro‑apoptotic effect was accompanied with increases in the expression of apoptotic protein Bim. Following resveratrol treatment, Akt-mediated phosphorylation of FoxO3a was observed to be diminished in HepG2 cells. Furthermore, resveratrol enhanced the nuclear levels of FoxO3a and mediated neuronal death via Bim. The present study demonstrated that resveratrol induced apoptosis in HepG2 cells through activation of the transcription factor FoxO3a and increasing the expression of Bim protein.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Gao Q, Shi Y, Wang X, Zhou J, Qiu S and Fan J: Translational medicine in hepatocellular carcinoma. Front Med. 6:122–133. 2012. View Article : Google Scholar : PubMed/NCBI
3	Pervaiz S and Holme AL: Resveratrol: Its biologic targets and functional activity. Antioxid Redox Signal. 11:2851–2897. 2009. View Article : Google Scholar : PubMed/NCBI
4	Foti Cuzzola V, Ciurleo R, Giacoppo S, Marino S and Bramanti P: Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: Focus on recent discoveries. CNS Neurol Disord Drug Targets. 10:849–862. 2011. View Article : Google Scholar : PubMed/NCBI
5	Zordoky BN, Robertson IM and Dyck JR: Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta. 1852:1155–1177. 2015. View Article : Google Scholar
6	Signorelli P and Ghidoni R: Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J Nutr Biochem. 16:449–466. 2005. View Article : Google Scholar : PubMed/NCBI
7	Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M and Sinclair D: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 430:686–689. 2004. View Article : Google Scholar : PubMed/NCBI
8	Delmas D, Jannin B, Cherkaoui Malki M and Latruffe N: Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep. 7:847–852. 2000.PubMed/NCBI
9	Parekh P, Motiwale L, Naik N and Rao KV: Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp Toxicol Pathol. 63:167–173. 2011. View Article : Google Scholar
10	Weng SC, Kashida Y, Kulp SK, Wang D, Brueggemeier RW, Shapiro CL and Chen CS: Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther. 7:800–808. 2008. View Article : Google Scholar : PubMed/NCBI
11	Khan A, Aljarbou AN, Aldebasi YH, Faisal SM and Khan MA: Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway. Cancer Epidemiol. 38:765–772. 2014. View Article : Google Scholar : PubMed/NCBI
12	Nho RS and Hergert P: FoxO3a and disease progression. World J Biol Chem. 5:346–354. 2014. View Article : Google Scholar : PubMed/NCBI
13	Liu MH, Yuan C, He J, Tan TP, Wu SJ, Fu HY, Liu J, Yu S, Chen YD, Le QF, et al: Resveratrol Protects PC12 cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a pathway. Cell Mol Neurobiol. 35:513–522. 2015. View Article : Google Scholar
14	Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, Peng SL, Jope RS and Li X: Forkhead box, class O transcription factors in brain: Regulation and behavioral manifestation. Biol Psychiatry. 65:150–159. 2009. View Article : Google Scholar :
15	Su JL, Cheng X, Yamaguchi H, Chang YW, Hou CF, Lee DF, Ko HW, Hua KT, Wang YN, Hsiao M, et al: FOXO3a-dependent mechanism of E1A-Induced chemosensitization. Cancer Res. 71:6878–6887. 2011. View Article : Google Scholar : PubMed/NCBI
16	Wang JG, Zheng XX, Zeng GY, Zhou YJ and Yuan H: Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma. Oncol Rep. 31:488–496. 2014.
17	Carbajo-Pescador S, Steinmetz C, Kashyap A, Lorenz S, Mauriz JL, Heise M, Galle PR, González-Gallego J and Strand S: Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells. Br J Cancer. 108:442–449. 2013. View Article : Google Scholar :
18	He L, Yang X, Cao X, Liu F, Quan M and Cao J: Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma. Oncol Rep. 29:103–108. 2013.
19	Izzotti A: Molecular medicine and the development of cancer chemopreventive agents. Ann N Y Acad Sci. 1259:26–32. 2012. View Article : Google Scholar : PubMed/NCBI
20	Pirola L and Fröjdö S: Resveratrol: One molecule, many targets. IUBMB Life. 60:323–332. 2008. View Article : Google Scholar : PubMed/NCBI
21	Tzivion G, Dobson M and Ramakrishnan G: FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta. 1813:1938–1945. 2011. View Article : Google Scholar : PubMed/NCBI
22	Hong ZY, Lee HJ, Shin DY, Kim SK, Seo M and Lee EJ: Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines. Cancer Lett. 314:34–40. 2012. View Article : Google Scholar
23	Roy SK, Chen Q, Fu J, Shankar S and Srivastava RK: Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One. 6:e251662011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles